Aquaculture genetics specialist, Xelect, has launched a new service providing independent genetic audits to help evaluate the value of a company’s broodstock.
The team’s new BioAudit combines specialist genetics skills with deep industry know-how and will give investors and buyers a wealth of new insights to help them make more informed decisions.
“The team here are truly unique, with a highly specialised set of skills and backgrounds,” explained operations director, Dr Tom Ashton. “This means that, as well as a genetics audit, we can offer a wide ranging biological due diligence service, covering feasibility of production targets, a biosecurity review, environmental and animal welfare checks and analysis of harvesting and processing practices.”
Recent examples of BioAudit projects by Xelect include providing buy side advice to the sovereign wealth fund of a prominent Middle Eastern country and a high profile due diligence project for a major sea bass and sea bream transaction.
Xelect’s chief executive, Professor Ian Johnston, said that every BioAudit project was tailored for the client. “It typically includes a site visit, interviews with key personnel and a detailed genetic analysis of the broodstock at our custom-built laboratory,” he said.
“Customers get a detailed report and presentation, highlighting any risks from inbreeding or past genetic management, and an assessment of whether there is sufficient genetic diversity for selective breeding to improve key commercial traits – all key factors for the future sustainability and profitability of the business,” he added.